SOX2 and gastric cancer: Changes in the expression of three pluripotency factors (KLF4, Nanog, and SOX2) except OCT4 were examined in the gastric cancer cells treated with cisplatin or TRAIL for 72 h by western blotting (Figure 3C,D).